Hugh O'Dowd Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hugh O'Dowd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hugh O'Dowd. Hugh O'Dowd is a Director in PUMA BIOTECHNOLOGY, INC. ($PBYI) and a President & CEO in Neon Therapeutics, Inc. ($NTGN).
Address: C/O NEON THERAPEUTICS, INC. 40 ERIE STREET, SUITE 110 CAMBRIDGE 02139 MA
Companies in which Hugh O'Dowd is an Insider
Neon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hugh O'Dowd: President & CEO
Holdings: 0 shares
Latest Transaction: May 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PUMA BIOTECHNOLOGY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hugh O'Dowd: Director
Holdings: 25,748 shares
Current Value: $871,570
Latest Transaction: Jun 11 2020
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Hugh O'Dowd
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2020 | PBYI | PUMA BIOTECHNOLOGY ... | O'Dowd Hugh | Director | Grant | A | 0.00 | 25,748 | 0 | 25,748 | 0 to 25.7 K |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 2.65 | 354,632 | 939,775 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 6.13 | 200,000 | 1,226,000 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Option Exercise | D | 10.20 | 208,062 | 2,122,232 | 0 | |
| May 06 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Sell | D | 0.00 | 776,085 | 0 | 0 | 776.1 K to 0 (-100.00 %) |
| Mar 02 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Payment of Exercise | F | 1.50 | 9,783 | 14,675 | 776,085 | 785.9 K to 776.1 K (-1.24 %) |
| Jan 13 2020 | NTGN | Neon Therapeutics, ... | O'Dowd Hugh | President & CEO | Grant | A | 0.00 | 240,000 | 0 | 785,868 | 545.9 K to 785.9 K (+43.97 %) |